An overview of expected approval dates for weight loss medications currently in clinical trials Oral Semaglutide: A New Daily Weight Loss Tablet Oral semaglutide, a groundbreaking weight loss drug, is classified as a GLP-1 agonist and is set to transform the landscape of obesity treatment
Available at: Hartman ML, et al
1 Introduction Melanoma represents the most aggressive and lethal form of skin cancer, characterized by its rapid progression, high metastatic potential, and notable resistance to conventional therapies ( A hallmark of melanoma malignancy is its ability to evade programmed cell death, which contributes to tumor progression and therapeutic resistance ( Ferroptosis, an iron-dependent form of regulated cell death characterized by the accumulation of lipid peroxides and reactive oxygen species (ROS), has emerged as a particularly promising target in melanoma therapy ( In addition to ferroptosis, other non-apoptotic RCD pathways such as pyroptosis and necroptosis have gained attention for their roles in melanoma biology and therapy ( The immunogenic nature of ferroptosis, pyroptosis, and necroptosis is particularly relevant in the context of melanoma immunotherapy

Ferroptosis, on the other hand, accelerates follicular depletion and is closely associated with common adverse factors implicated in DOR, such as aging, genetic mutations, OS, radiation, and cancer therapies
Magnesium provides osmotic relief
Fasting, zone 2 exercise, and proper sleep can naturally enhance growth hormone during off cycles